News

Thyrocare Technologies Limited (hereinafter referred to as THYROCARE NSE: THYROCARE, BSE: 539871), a leading healthcare diagnostics company, has announced its financial results for the first quarter ...
Thyrocare Technologies Limited reported a robust 23% year-on-year revenue growth in Q1FY26. The company's core Pathology segment significantly contributed to this surge.
Dr. A Velumani, Thyrocare's founder, advises parents against overindulging their children, emphasizing the crucial roles of ...
Net Sales at Rs 178.89 crore in June 2025 up 24.55% from Rs. 143.63 crore in June 2024. Quarterly Net Profit at Rs. 36.05 crore in June 2025 up 43.34% from Rs. 25.15 crore in June 2024. EBITDA stands ...
Thyrocare: The company is in the process of deploying SigTuple AI100 across its laboratories. As a pilot, installations have been done in the labs at Lucknow, Nagpur and Ranchi where a panel of ...
While Thyrocare Technologies doesn't seem to have gained much on the EBIT line, at least earnings remain stable for now. There's no doubt that we learn most about debt from the balance sheet.
Thyrocare Technologies shares zoomed 12.66 per cent in trade, hitting a 52-week high at ₹1,356.95 per share on the BSE.
Thyrocare’s senior citizen packages are thus made to help with detailed analysis of thing slike heart, liver, kidney, etc. These bundled packages make routine health monitoring for seniors more ...
Thyrocare founder Dr. A Velumani sparks debate with his viral video criticizing the over-scheduling of city children. He ...
Thyrocare’s consolidated net profit rose 59.9% to INR 38.3 Cr in Q1 FY26 from INR 23.9 Cr in the year-ago quarter ...
Mumbai: Thyrocare unveiled its new brand identity that reflects the dramatic transformation of the company over the last 25 years. The new logo, with its bold look and feel, reflects the dynamic ...
What struck him most was Redcliffe Labs’ pace. “Had an hour of interaction on how it is going for @Redcliffe Labs. I hear a growth in 3 years a turnover that I took 15 years to reach,” he wrote.